A phase II study of combination epigenetic therapy in metastatic colorectal cancer (mCRC): A phase II consortium (P2C)/Stand Up 2 Cancer (SU2C) study. This is an ASCO Meeting Abstract from the 2013 ...
Efficacy of Skin-Directed Therapy for Cutaneous Metastases From Advanced Cancer: A Meta-Analysis QST results were collected for 27 patients with a diagnosis of MM and compared with data collected from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback